Literature DB >> 1467973

The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat.

J L Cadet1, S M Zhu.   

Abstract

Unilateral injections of 6-hydroxydopamine into the striatum resulted in almost immediate ipsilateral amphetamine (AMPH)- and delayed contralateral apomorphine (APO)-induced circling behavior in rats. APO-induced rotation correlated positively with that caused by AMPH. In these animals, there was an almost complete disappearance of dopamine uptake sites as well as increases in DA D2 receptors in specific subdivisions of the ipsilateral caudate-putamen (CPu). Both the rate of AMPH- and APO-induced rotation correlated with the percentage of DA terminal loss in the total aspect and in various quadrants of the striatum. In contrast, AMPH- and APO-induced rotation correlated with the percentage increase in striatal D2 receptors only in the dorsolateral (DL) aspect of the CPu. These results indicate that both AMPH- and APO-induced rotation can be used to determine the extent of DA terminal loss in the rat basal ganglia. The positive correlation of circling behavior to only changes in DA D2 receptors observed in the DL striatal subdivision provides further evidence for the heterogeneity of the basal ganglia. This model of hemiparkinsonism in the rat which uses a distant intrastriatal approach to the destruction of nigral DA cell bodies may be a more appropriate model to study the regenerative properties of the nigrostriatal DA system. This approach could also be used to more specifically localize peptidergic receptors on midbrain dopamine cell bodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1467973     DOI: 10.1016/0006-8993(92)91066-n

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease.

Authors:  Ho-Joo Lee; Richard P Bazinet; Stanley I Rapoport; Abesh Kumar Bhattacharjee
Journal:  Neurochem Res       Date:  2009-12-08       Impact factor: 3.996

3.  The effect of dopamine D1 receptor stimulation on the up-regulation of histamine H3-receptors following destruction of the ascending dopaminergic neurones.

Authors:  J H Ryu; K Yanai; X L Zhao; T Watanabe
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Induced pluripotent stem cells in rat models of Parkinson's disease: A systematic review and meta-analysis.

Authors:  Yunxia Zhang; Meiling Ge; Qiukui Hao; Birong Dong
Journal:  Biomed Rep       Date:  2018-01-30

5.  Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.

Authors:  Abesh Kumar Bhattacharjee; Lixin Lang; Orit Jacobson; Bidhan Shinkre; Ying Ma; Gang Niu; William C Trenkle; Kenneth A Jacobson; Xiaoyuan Chen; Dale O Kiesewetter
Journal:  Nucl Med Biol       Date:  2011-03-30       Impact factor: 2.408

6.  Subdivisional ischemic injury of the unilateral striatum causes apomorphine-induced rotational behavior in rats.

Authors:  S Goto; S Nagahiro; K Korematsu; K Kogo; Y Ushio
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Imaging apomorphine stimulation of brain arachidonic acid signaling via D2-like receptors in unanesthetized rats.

Authors:  Abesh Kumar Bhattacharjee; Lisa Chang; Laura White; Richard P Bazinet; Stanley I Rapoport
Journal:  Psychopharmacology (Berl)       Date:  2008-02-15       Impact factor: 4.530

8.  In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease.

Authors:  Abesh Kumar Bhattacharjee; Lindsey M Meister; Lisa Chang; Richard P Bazinet; Laura White; Stanley I Rapoport
Journal:  Neuroimage       Date:  2007-06-27       Impact factor: 6.556

Review 9.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

10.  Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease.

Authors:  Laurence Mignon; William A Wolf
Journal:  Psychopharmacology (Berl)       Date:  2007-01-31       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.